Antimicrobial Resistance: Epidemiological alerts and updates
16 April 2019 - Epidemiological Alert on Outbreaks of resistant microorganisms associated with medical tourism
In recent years, several outbreaks caused by multiresistant bacteria have been reported in the Region of the Americas, some of which were healthcare-associated infections. Reducing the incidence of these types of infections is part of the framework of the Plan of Action on Antimicrobial Resistance.
7 March 2014: Carbapenemases of type New Delhi Metallo-?-lactamase (NDM) – update
In light of the spread of microorganisms with the New Delhi Metallo-?-lactamase (NDM) resistance mechanism, both across bacterial species and across geographic boundaries, the Pan American Health Organization / World Health Organization (PAHO/WHO) emphasizes the importance of strengthening established surveillance and control strategies to prevent further spread of this resistance mechanism.
27 June 2013: Vancomycin-resistant Staphylococcus aureus – situation in the Americas
In light of the isolation of the first Staphylococcus aureus resistant to vancomycin in Latin America, the Pan American Health Organization/World Health Organization (PAHO/WHO) recommends that Member States continue to establish and maintain their capacity for rapid detection and reporting of this resistance mechanism to antibiotics for the implementation of infection prevention and control measures associated with health care.
19 December 2012: Nosocomial transmission of NDM-type multiresistant bacteria – situation in the Americas
The Pan American Health Organization (PAHO) / World Health Organization (WHO) recommends that Member States increase their efforts to implement prevention and control actions for infections associated with health care, due to the detection and local spread of mutli-resistant microorganisms with New Delhi Metallo-?-lactamase-type (NDM) antimicrobial resistance mechanisms in health services in countries of the Americas.
22 November 2011 – Carbapenemases of type New Delhi Metallo-β-lactamase (NDM)
Due to the recent finding of carbapenemasas of New Delhi metalobetalactamasa (NDM) type in isolations of Klebsiella pneumoniae in Guatemala, the Pan American Health Organization/World Health Organization (PAHO/WHO) emphasizes the importance of the surveillance and detection in the Region of this resistance mechanism that increases morbidity and mortality of the infections associated with health care.
15 July 2011: Multi-Resistant Neisseria gonorrhoeae – situation in the Americas
In light of the identification by scientific communities of a strain of gonorrhea resistant to all microbial treatments available for sexually transmitted infections (STIs), the Pan American Health Organization recommends informing health workers, institutions, and nongovernmental organizations that work in the prevention and control of STIs about the risk of resistance in this strain, and in particular strengthen the surveillance in each country regarding the appearance of strains with an unusual profile. The Organization also recommends promoting the use of STI prevention methods.
2 July 2010 Carbapenemases in Klebsiella Pneumoniae in Latin-America
Recently, the INEI-ANLIS "Dr. Carlos G. Malbrán" Laboratory in Buenos Aires, Argentina, published a national alert on the dissemination of carbapenemases in Argentina. This laboratory is responsible for the external quality assurance program of the Latin American Network for Monitoring Antimicrobial Resistance, coordinated by PAHO. In this alert, the laboratory reported an increase of 800% in isolations of enterobacterium with carbapenemases in the first four-month period of 2010, in comparison to the same period in the previous year.